Rapid rewarming dissolver for pulmonary alveoli surface active substances

Abstract

The invention relates to the field of medical instruments, and particularly discloses a rapid rewarming dissolver for pulmonary alveolar surface active substances, which comprises a heating cylinder and further comprises a water bath heating unit, a containing frame for containing medicine bottles is arranged in the heating cylinder, and the water bath heating unit comprises an electric heating wire capable of heating a water bath and a constant temperature control module electrically connected with the electric heating wire. The electric heating wire and the constant temperature control module are both fixedly installed in the heating cylinder. According to the scheme, the medicine is rewarmed in a water bath mode, so that the medicine in the medicine bottle is rewarmed uniformly and rapidly, the whole rewarming time is controlled to be 1-2 min, the medicine can be rewarmed rapidly, meanwhile, the medicine can be dissolved rapidly, and then the medicine can be applied to the rescue and treatment process of premature infants and critical newborns.

Description

technical field [0001] The invention belongs to the field of medical devices, in particular to a rapid rewarming dissolver for alveolar surfactant. Background technique [0002] my country is a country with a large population, and the number of premature babies in my country ranks second in the world. In recent years, the incidence of premature babies in my country has increased year by year. Due to the lack of alveolar surfactant, premature infants are prone to hyaline membrane disease of premature infants, also known as neonatal respiratory distress syndrome, and newborns are also prone to secondary alveolar surfactant due to infection, asphyxia and hypoxia after birth. Deficiency, these are critical and severe diseases that endanger newborns. Now with the widespread use of alveolar surfactant and the continuous improvement of newborn rescue technology, more and more premature and critically ill newborns can survive. The use of pulmonary surfactant is a key technology fo...

AI Technical Summary

Problems solved by technology

[0005] The present invention intends to provide a rapid rewarming dissolver for alveolar surface active substances to solve the problems that the rewarming time of Kelisu is long and the dissolution speed is slow, and the rewarming time of Cursu medicine is long, which is not conducive to the timely rescue of premature infants and critically ill newborns.

Images